GW Pharmaceuticals Could Make Major Splash in U.S. Cannabis Industry

GW Pharma

By Omar Sacirbey

A British company that develops cannabis-based medicine is on the verge of a major breakthrough that could ripple across the U.S. marijuana industry.

GW Pharmaceuticals will likely seek FDA approval in the fourth quarter of this year to sell an epilepsy drug derived from marijuana, according to an analyst who follows the company.

If it wins that approval, GW Pharmaceuticals could start sales in the U.S. by the end of 2017, giving it access to a potentially billion-dollar…

CONTINUE READING: Click Here to Continue Reading Article …